Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Phenylpiracetam is a synthetic derivative of the nootropic drug piracetam. It has been studied primarily in Russia for its potential cognitive and neurological benefits, including effects on coordination. The scientific evidence for phenylpiracetam's use in supporting or treating coordination comes largely from small clinical trials and animal studies. In clinical settings, phenylpiracetam has been investigated for its potential to improve motor function and coordination in patients with neurological conditions such as stroke or brain injury. Some studies have reported improvements in motor coordination, increased physical endurance, and reduced motor deficits in these populations. For example, a few Russian studies have suggested that phenylpiracetam may help restore motor skills and coordination in post-stroke patients, though these studies are limited in size and methodology.

The proposed mechanisms for these effects include modulation of neurotransmitter systems (e.g., acetylcholine, dopamine), neuroprotection, and enhancement of neuronal energy metabolism. However, the quality and quantity of peer-reviewed, large-scale studies in humans are limited, and most evidence originates from non-English language sources with variable methodological rigor. As a result, while there is some scientific basis for phenylpiracetam’s use in supporting coordination, the overall strength of the evidence is moderate to weak, meriting a score of 2 out of 5. More robust, well-controlled clinical trials are needed to confirm its efficacy and safety for this indication.

More about phenylpiracetam
More about Coordination

Other ingredients used for Coordination

Other health conditions supported by phenylpiracetam

Products containing phenylpiracetam